Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Teijin Pharma to launch Feburic in Japan for hyperuricemia

May 17, 2011

Sanford Project and DiaMedica complete animal study of DM-199

May 16, 2011

Novartis claims new sodium/glucose cotransporter 2 inhibitors

May 16, 2011

Santaris Pharma advances second cardiometabolic compound into phase I trials

May 13, 2011

New fatty acid synthase inhibitors prepared

May 13, 2011

Novartis patents new sodium/glucose cotransporter inhibitors

May 13, 2011

FDA accepts EffRx's NDA for EX-101 for osteoporosis

May 13, 2011

Biodel's ultrarapidly acting insulin formulations enter pump trial in type 1 diabetes

May 12, 2011

Novel free fatty acid FFA1 receptor agonists for diabetes claimed by Lilly

May 12, 2011

Takeda and Pronova report on pivotal Japanese trial of TAK-085 in hypertriglyceridemia

May 10, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...